Literature DB >> 12076798

Regulation of the Legionella mip-promotor during infection of human monocytes.

Hagen Wieland1, Marion Faigle, Florian Lang, Hinnak Northoff, Birgid Neumeister.   

Abstract

The opportunistic pathogen Legionella pneumophila, the etiologic agent of Legionnaires disease, is able to invade and multiply intracellularly in human macrophages. This process is controlled by several bacterial virulence factors. As recently demonstrated, one of these virulence factors, the macrophage infectivity potentiator (Mip) protein, is important for invasion and proper intracellular establishment of L. pneumophila in macrophages and protozoa. Knockout mutants devoid of a functional mip-gene enter host cells much less effectively but intracellular replication is not affected. Using a P(mip)-green fluorescent protein reporter construct in L. pneumophila substrain Corby, P(mip) was recently shown to be constitutively active in replicating bacteria. A stringent regulation during the infection process could not be observed, neither in intracellular nor in BYE broth-grown bacteria. For enhanced temporal and quantitative resolution, we examined the activity of mip on RNA level in order to detect short transient regulatory events. Our results show that P(mip) of L. pneumophila is temporarily repressed directly after invasion of the monocytic human cell line MonoMac 6 and regains activity after 24 h of intracellular replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076798     DOI: 10.1111/j.1574-6968.2002.tb11255.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  Genetic evidence that Legionella pneumophila RpoS modulates expression of the transmission phenotype in both the exponential phase and the stationary phase.

Authors:  Michael A Bachman; Michele S Swanson
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Role of biofilm in protection of the replicative form of Legionella pneumophila.

Authors:  Elisa Andreozzi; Andrea Di Cesare; Luigia Sabatini; Elisa Chessa; Davide Sisti; Marco Rocchi; Barbara Citterio
Journal:  Curr Microbiol       Date:  2014-07-15       Impact factor: 2.188

Review 3.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.

Authors:  Miao-Chiu Hung; Omar Salim; Jeannette N Williams; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

5.  Legionella pneumophila Mip, a surface-exposed peptidylproline cis-trans-isomerase, promotes the presence of phospholipase C-like activity in culture supernatants.

Authors:  Sruti Debroy; Virginia Aragon; Sherry Kurtz; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

6.  MIP From Legionella pneumophila Influences the Phagocytosis and Chemotaxis of RAW264.7 Macrophages by Regulating the lncRNA GAS5/miR-21/SOCS6 Axis.

Authors:  Youfeng Shen; Jian Xu; Shenshen Zhi; Wenyan Wu; Yingying Chen; Qiang Zhang; Yan Zhou; Ze Deng; Wei Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

7.  Sel1 repeat protein LpnE is a Legionella pneumophila virulence determinant that influences vacuolar trafficking.

Authors:  Hayley J Newton; Fiona M Sansom; Jenny Dao; Adrian D McAlister; Joan Sloan; Nicholas P Cianciotto; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

8.  Characterization of two putative Dichelobacter nodosus footrot vaccine antigens identifies the first lysozyme inhibitor in the genus.

Authors:  Maria Victoria Humbert; Alexandra Jackson; Christian M Orr; Ivo Tews; Myron Christodoulides
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.